ClinicalTrials.gg
Enrolling by invitationNCT06680271Updated Dec 18, 2024

Exercise Prescription Via Telerehabilitation for Older Adults With Cardiopulmonary Disease in Antioquia, Colombia

An interventional study of Remote exercise and Home exercise in Telerehabilitation, Exercise and Noncommunicable Disease, sponsored by Fundacion Universitaria Maria Cano. Enrolling by invitation at 1 site in Colombia. Open to participants aged 60 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-12-18.

Primary conditionNoncommunicable DiseasesRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Noncommunicable Diseases
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Noncommunicable Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Fundacion Universitaria Maria Cano · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
60 Years to 100 Years
Sex
All
01

Study summary

Objective: To evaluate the effects of telerehabilitation with physical exercise in older adults with cardiorespiratory disease in Antioquia, Colombia.

Methods: This study will be a single controlled trial conducted at a single center. A sample of 50 older adults with cardiorespiratory diseases will be included. The intervention group will consist of 25 subjects receiving a multicomponent physical exercise intervention (aerobic, strength, flexibility, and neuromotor) delivered by a physical therapist via the Microsoft Teams platform. The control group will consist of 25 subjects receiving traditional physical therapy at home from a physical therapist. The intervention will be pre-registered on "ClinicalTrials.gov".

Expected Results: An improvement in quality of life, measured by the WHOQOL-Bref (World Health Organization Quality of Life), an increase in physical condition assessed with the Senior Fitness Test battery, and a reduction in frailty measured by the Short Physical Performance Battery (SPPB) are expected. Additionally, the development of a cardiopulmonary telerehabilitation protocol is anticipated.

Read the detailed description

This study will explore the effects of prescribing physical exercise through telerehabilitation for older adults with cardiorespiratory diseases in Antioquia, Colombia. It will aim to determine which exercise prescriptions are most beneficial and feasible for this population within a telerehabilitation model, taking into account the specific conditions they face.

The study will address three main questions. First, it will identify which types of physical exercises are most suitable for older adults with various cardiorespiratory conditions when delivered via telerehabilitation. Second, it will examine how to best implement these exercises to ensure safety, engagement, and effectiveness through remote guidance. Finally, the study will evaluate the benefits of telerehabilitation-prescribed physical exercises, particularly regarding improvements in quality of life for older adults managing these health conditions.

02

Conditions studied

  • Telerehabilitation
  • Exercise
  • Noncommunicable Disease

Browse trials for

Keywords

  • Telerehabilitation
  • Physical Activity
03

In context

Noncommunicable Diseases Reclassified

144 studies on the registry are indexed under Noncommunicable Diseases; 55 are open to participants now.

This study's planned enrollment of 50 is below the median of 478 across 95 interventional studies indexed under Noncommunicable Diseases.

Browse Noncommunicable Diseases studies →

Lead sponsor

Fundacion Universitaria Maria Cano is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Compared within Noncommunicable Diseases, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Voluntarily agree to participate in the study.
  • Inclusion will be considered for individuals with specific chronic medical conditions, including (COPD), which will be diagnosed according to the guidelines established in the widely used Global Initiative for Chronic Obstructive Lung Disease (GOLD) guide in clinical and research contexts. Similarly, asthma will be included, identified according to the criteria outlined in the Global Initiative for Asthma (GINA) guide. Heart failure will also be included, categorized based on the (NYHA) functional classification previously validated in Colombian populations. Additionally, metabolic syndrome will be included, with confirmation based on criteria defined by the World Health Organization (WHO).
  • The patient's diagnosis must be confirmed through medical history.
  • These specific criteria will guide the selection of participants who meet the established requirements for this study.
  • Must be able to communicate verbally or in writing.
  • Must be in a stable phase of their illness, supported by medical history.
  • A minimum of 3 months of illness for the condition to be considered chronic.
  • Patients with Type II Diabetes Mellitus must have a glucose level lower than 200 mg/dL during the tele-rehabilitation session.

Exclusion criteria

Exclusion Criteria:

  • Dementia.
  • Epilepsy or a history of seizures.
  • Patient who has recently undergone surgery.
  • Delirium.
  • Acute myocardial infarction or recent unstable angina.
  • Uncontrolled atrial or ventricular arrhythmias.
  • Dissecting aortic aneurysm.
  • Severe aortic stenosis.
  • Acute endocarditis/pericarditis.
  • Uncontrolled hypertension.
  • Acute thromboembolic disease.
  • Severe acute heart failure.
  • Severe acute respiratory failure.
  • Uncontrolled orthostatic hypotension.
  • Diabetes mellitus with acute decompensation or uncontrolled hypoglycemia.
  • Recent fracture (within the last month, strength training).
  • Any other circumstance deemed by the evaluator or the subject that prevents physical activity.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Telehealth interventions

    The intervention group will consist of 25 subjects receiving a multicomponent physical exercise intervention (aerobic, strength, flexibility, and neuromotor) delivered by a physical therapist via the Microsoft Teams platform.

    Other: Remote exercise

  • Active comparator
    Home Intervention

    The control group will consist of 25 subjects receiving traditional physical therapy at home from a physical therapist

    Other: Home exercise

Interventions

  • OtherRemote exercise

    The intervention group will consist of 25 subjects receiving a multicomponent physical exercise intervention (aerobic, strength, flexibility, and neuromotor) delivered by a physical therapist via the Microsoft Teams platform

  • OtherHome exercise

    The control group will consist of 25 subjects receiving traditional physical therapy at home from a physical therapist.

06

What researchers measure

Primary outcomes

  1. Quality of Life - BREF (WHOQOL-BREF)

    The WHOQOL-BREF is a 26-item questionnaire covering four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items), along with items on overall quality of life and general health. Each item is rated on a 5-point ordinal scale, and scores are linearly transformed to a 0-100 scale.

    Time frame: Month 1 vs Month 3

Secondary outcomes

  1. Frailty SPPB (Short Physical Performance Battery)

    The SPPB will assess lower limb function through five tests covering balance, strength, and mobility. Balance tests will have three progressively challenging stages (feet together, semi-tandem, and full tandem), aiming for 10 seconds unaided at each stage. Gait speed will be measured with a portable gait analysis system. For the "five times sit-to-stand" test, participants will begin seated and, after demonstrating one sit-to-stand, will complete five repetitions as quickly as possible, with feet flat on the floor. Scores will reflect performance, with a maximum score of 12; lower scores indicate greater frailty in older adults.

    Time frame: Month 1 vs Month 3

  2. Senior Fitness Test- Physical Condition

    The Senior Fitness Test evaluates various physical fitness components for older adults: Lower Body Strength - Chair Stand Test (30 seconds): Measures leg strength by counting how many times a person can rise from a chair in 30 seconds. More repetitions are better. Upper Body Strength - Arm Curl Test: Counts how many arm curls can be completed in a set time (30 seconds). More repetitions are better. Aerobic Endurance - 6-Minute Walk Test: Assesses walking endurance over 6 minutes, measured in meters. More meters walked are better. Upper Body Flexibility - Back Scratch Test: Measures shoulder flexibility by attempting to touch hands behind the back. Greater reach is better. Lower Body Flexibility - Chair Sit and Reach Test: Assesses flexibility of the hamstrings and lower back, measured in centimeters. Greater reach is better.

    Time frame: Month 1 vs Month 3

07

Study locations

1 site
  • Silvia Betancur
    Envigado, Antioquia, Colombia
08

References and documents

Individual participant data

Plan to share: Yes — Data obtained through this study may be provided to qualified researchers with academic interest in telerehabilitation

Supporting information: Study protocol, Informed consent form

Time frame: Data requests can be submitted starting 12 months after article publication and the data will be made accessible for up to 24 months.

Access criteria: Access to trial Individual Patient Data (IPD) is available to qualified researchers conducting independent scientific research. Requests will be granted after review and approval of a research proposal. For more information or to submit a request, please contact principal researcher.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2025; primary completion for Sep 2025, 6 months later.

Of 78 non-industry interventional studies with no phase under Noncommunicable Diseases, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 6 months is below that.

Counting every sponsor, half of 78 studies reached it within 17 months; a quarter within 7 and three quarters within 30.

Noncommunicable Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2024
First posted
Nov 8, 2024
StartEst.
Mar 1, 2025
Primary completionEst.
Sep 30, 2025
CompletionEst.
Nov 30, 2025
Last update
Dec 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06680271
Lead sponsor
Fundacion Universitaria Maria Cano
Responsible party
Silvia Patricia Betancur Bedoya (Professor, Universidad Iberoamericana A.C., Mexico) — Principal investigator
First posted
Nov 8, 2024
Start date
Mar 1, 2025 (estimated)
Primary completion
Sep 30, 2025 (estimated)
Completion
Nov 30, 2025 (estimated)
Last update
Dec 18, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion